abagovomab 7
abciximab 14
abituzumab 4
abrilumab 7
actoxumab 6
adalimumab 7
aducanumab 3
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 18
alirocumab 6
amatuximab 13
andecaliximab 9
anifrolumab 7
anrukinzumab 7
aprutumab 6
aprutumab_ixadotin 6
arcitumomab 6
ascrinvacumab 0
atezolizumab 9
atinumab 9
avelumab 6
basiliximab 3
bavituximab 7
begelomab 5
benralizumab 6
bevacizumab_beta 3
bezlotoxumab 6
bimagrumab 8
bleselumab 0
blinatumomab 12
blosozumab 19
bococizumab 11
brazikumab 0
brentuximab_vedotin 3
briakinumab 6
brodalumab 0
brolucizumab 14
brontictuzumab 10
burosumab 10
cabiralizumab 7
camrelizumab 3
canakinumab 12
cantuzumab_ravtansin 16
carlumab 7
carotuximab 3
cergutuzumab_amunaleukin2 21
cergutuzumab_amunaleukin 21
certolizumab_pegol 10
cetiximab 17
citatuzumab_bogatox 18
cixutumumab 12
clivatuzumab_tetraxetan 4
codrituzumab 15
conatumumab 3
concizumab 6
crenezumab 6
crizanlizumab 3
crotedumab 9
dacetuzumab 14
daclizumab 5
dalotuzumab 13
dapirolizumab_pegol 15
daratumumab 10
dectrekumab 3
demcizumab 10
denosumab 7
depatuxizumab 8
depatuxizumab_mafodotin 8
dezamizumab 0
dinutuximab 17
diridavumab 0
domagrozumab 5
drozitumab 4
duligotuzumab 11
durvalumab 0
dusigitumab 0
efalizumab 20
efungumab 9
eldelumab 4
elezanumab 3
elgemtumab 0
elotuzumab 4
emactuzumab 7
emapalumab 8
emibetuzumab 5
enavatuzumab 19
enfortumab_vedotin 0
enoblituzumab 7
enokizumab 8
enoticumab 8
ensituximab 10
eptinezumab 8
erenumab 3
etaracizumab 9
etrolizumab 13
evinacumab 12
evolocumab 3
farletuzumab 0
fasinumab 10
fezakinumab 3
fibatuzumab 0
ficlatuzumab 8
firivumab 15
flanvotumab 4
fletikumab 11
foralumab 3
foravirumab 10
fremanezumab 12
fresolimumab 10
fulranumab 13
futuximab 4
galcanezumab 0
ganitumab 13
gantenerumab 0
gemetuzumab 14
gemtuzumab2 16
gemtuzumab 6
gevokizumab 11
girentuximab 10
glembatumumab 8
glembatumumab_vedotin 8
guselkumab 11
ibalizumab 10
ibritumomab 5
icrucumab 5
idarucizumab 6
ifabotuzumab 0
imalumab 10
imgatuzumab 9
inclacumab 8
indatuximab_ravtansin 12
indusatumab 5
inebilizumab 10
intetumumab 3
iodine_girentuximab 14
ipilimumab 0
iratumumab 4
isatuximab 5
itolizumab 13
ixekizumab 11
labetuzumab_govitecan 13
lambrolizumab 11
lampalizumab 10
lanadelumab 12
landogrozumab 9
laprituximab 14
lebrikizumab 15
lendalizumab 16
lenzilumab 4
lifastuzumab_vedotin 6
ligelizumab 7
lilotomab 13
lirilumab 5
lodelcizumab 6
lokivetmab 7
lorvotuzumab_mertansin 0
lucatumumab 17
lumretuzumab 0
lupartumab 6
lutikizumab 9
margetuximab 17
milatuzumab 11
mirvetuximab 16
mirvetuximab_soravtansin 16
modotuximab 18
mogamulizumab 13
monalizumab 11
motavizumab 15
moxetumomab_pasudotox 7
namilumab 4
naratuximab 9
naratuximab_emtansin 9
narnatumab 8
navicixizumab2 15
navicixizumab 10
navivumab 4
necitumumab 3
nemolizumab 12
nesvacumab 8
nivolumab 5
obiltoxaximab 3
obinutuzumab 18
ocaratuzumab 12
ofatumumab 4
olaratumab 0
olokizumab 15
omalizumab 11
onartuzumab 9
ontuxizumab 0
opicinumab 11
orticumab 3
otelixizumab 10
oxelumab 4
ozanezumab 5
pamrevlumab 0
panobacumab 6
parsatuzumab 9
pasotuxizumab 16
pateclizumab 9
patritumab 9
pembrolizumab 11
perakizumab 6
pidilizumab 8
pinatuzumab_vedotin 5
plozalizumab 5
pogalizumab 8
polatuzumab_vedotin 11
ponezumab 11
prezalumab 10
pritoxaximab 11
quilizumab 8
racotumomab 10
radretumab 4
ralpancizumab 16
ramucirumab 7
ranevetmab 12
ranibizumab 3
refanezumab 7
remtolumab 8
rilotumumab 3
rinucumab 0
risankizumab 20
rituximab 3
rivabazumab 8
robatumumab 17
roledumab 9
romosozumab 7
rontalizumab 13
rosmantuzumab 10
rozanolixizumab 5
sacituzumab 6
sacituzumab_govitecan 6
samalizumab 11
sapelizumab 10
sarilumab 0
secukinumab 5
seribantumab 11
setoxaximab 15
sifalimumab 0
siltuximab 7
simtuzumab 14
sirukumab 7
solanezumab 18
solitomab 4
stamulumab 6
suptavumab 13
suvizumab 0
tabalumab 0
tadocizumab 0
tamtuvetmab 18
tanezumab 12
tarextumab 5
tavolixizumab 6
telisotuzumab 15
teplizumab 8
tesidolumab 6
tezepelumab 4
tigatuzumab 11
tildrakizumab 8
timolumab 5
tisotumab 4
tosatoxumab 14
tositumomab 5
tralokinumab 14
trastuzumab 18
tregalizumab 15
trevogrumab 7
ublituximab 11
urelumab 3
ustekinumab 10
utomilumab 11
vadastuximab 9
vadastuximab_talirin 9
vandortuzumab_vedotin 4
vantictumab 7
vanucizumab2 3
vanucizumab 7
varlilumab 11
vatelizumab 8
vedolizumab 0
veltuzumab 0
vesencumab 0
vorsetuzumab 12
vorsetuzumab_mafodotin 12
vunakizumab 13
xentuzumab 7
zatuximab 18
